Daytime Measurements Underestimate Nocturnal Oxygen Desaturations in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

被引:40
|
作者
Hildenbrand, Florian F.
Bloch, Konrad E. [2 ]
Speich, Rudolf [3 ]
Ulrich, Silvia [1 ]
机构
[1] Univ Zurich Hosp, Resp Clin, Div Pulm, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Sleep Disorders Ctr, Dept Thorac & Cardiovasc Med, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Clin Internal Med, CH-8091 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Chronic thromboembolic pulmonary hypertension; Pulmonary arterial hypertension; Sleep disordered breathing; CHEYNE-STOKES RESPIRATION; EXERCISE PERFORMANCE; HEART-FAILURE; SLEEP; GUIDELINES; DIAGNOSIS; THERAPY; DISEASE; ADULTS;
D O I
10.1159/000341182
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Nocturnal hypoxemia is important in precapillary pulmonary hypertension (pPH) as it worsens pulmonary hemodynamics. Whether daytime oxygen saturation (SpO(2)) predicts nocturnal hypoxemia in pPH patients has not been conclusively studied. Objectives: To investigate the prevalence of nocturnal hypoxemia in comparison to daytime SpO(2) and disease severity in ambulatory patients with pulmonary hypertension. Methods: Consecutive patients diagnosed with pPH classified as either pulmonary arterial (PAH) or chronic thromboembolic pPH (CTEPH) had daytime resting and exercise SpO(2) (at the end of a 6-min walk test); thereafter, they underwent overnight pulse oximetry at home. Functional class, pro-brain natriuretic peptide (pro-BNP) and the tricuspid pressure gradient were assessed. Results: Sixty-three patients [median (quartiles) age 62 (53; 71), 43 females] with PAH (n = 44) and CTEPH (n = 19) were included. The resting SpO(2), exercise SpO(2), and mean nocturnal SpO(2) were 95% (92; 96), 88% (81; 95), and 89% (85; 92), respectively. Forty-nine patients (77%) spent >10% of the night with SpO(2) <90% (desaturators), and 33 (52%) spent >50% of the night with SpO(2) <90% (sustained desaturators). The positive predictive values of daytime SpO(2) >90% for being a nocturnal nondesaturator or sustained nondesaturator were 25 and 53%, respectively. Nocturnal SpO(2) was negatively correlated with the tricuspid pressure gradient, but not with functional class, 6-min walk test, or pro-BNP. Conclusions: Nocturnal hypoxemia is very common in PAH and CTEPH despite often normal daytime SpO(2) and reflects disease severity. Nocturnal pulse oximetry should be considered in the routine evaluation of pPH patients and research should be directed toward the treatment of nocturnal desaturation in pPH. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:477 / 484
页数:8
相关论文
共 50 条
  • [1] Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension
    Hildenbrand, Florian
    Bloch, Konrad E.
    Speich, Rudolf
    Ulrich, Silvia
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Pulmonary hypertension: evolution of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Anderson, Ryan J.
    Malhotra, Atul
    Kim, Nick H.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S562 - S565
  • [3] Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
    Humbert, M.
    EUROPEAN RESPIRATORY REVIEW, 2010, 19 (115): : 59 - 63
  • [4] Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Bishop, Bryan M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (21) : 1839 - 1844
  • [5] RIOCIGUAT FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Larche, N. E.
    Mousa, S. A.
    DRUGS OF TODAY, 2013, 49 (12) : 761 - 768
  • [6] Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Humbert, Marc
    Farber, Harrison W.
    Ghofrani, Hossein-Ardeschir
    Benza, Raymond L.
    Busse, Dennis
    Meier, Christian
    Hoeper, Marius M.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (06)
  • [7] Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
    Koudstaal, Thomas
    Boomars, Karin A.
    Kool, Mirjam
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [8] Oxygen uptake is more efficient in idiopathic pulmonary arterial hypertension than in chronic thromboembolic pulmonary hypertension
    Shi, Xiaofang
    Guo, Jian
    Gong, Sugang
    Sapkota, Rikesh
    Yang, Wenlan
    Liu, Hui
    Xiang, Wenjing
    Wang, Lan
    Sun, Xingguo
    Liu, Jinming
    RESPIROLOGY, 2016, 21 (01) : 149 - 156
  • [9] Nocturnal oxygen desaturation in pulmonary arterial hypertension
    Avecillas, JF
    Minai, O
    Foldvary, N
    Marlow, S
    Dinner, D
    Golish, J
    SLEEP, 2004, 27 : 330 - 330
  • [10] New class of drugs for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Delmonte, Jose A.
    INSUFICIENCIA CARDIACA, 2016, 11 (03) : 130 - 149